May 29, 2026 07:00AM

May 15, 2026 06:01AM

Apr 15, 2026 06:06AM

Apr 9, 2026 06:55AM

Mar 27, 2026 09:49AM

Mar 10, 2026 06:22AM

Mar 9, 2026 08:01AM William Blair Reiterates Outperform Rating on ARS Pharmaceuticals Inc (SPRY) following Q4 results

Mar 2, 2026 06:37AM

Dec 29, 2025 08:00AM

Nov 10, 2025 07:29AM

Nov 10, 2025 07:28AM

Nov 10, 2025 06:09AM

Nov 4, 2025 07:58AM

Oct 8, 2025 08:00AM ARS Pharmaceuticals wins European patent challenge for neffy spray

Sep 29, 2025 04:06PM

Sep 26, 2025 09:31AM

Sep 19, 2025 08:01AM

Sep 4, 2025 09:27AM

Aug 14, 2025 05:50AM

Aug 13, 2025 07:09AM

Jul 18, 2025 09:26AM U.K. approves ARS Pharmaceuticals' needle-free epinephrine nasal spray

Jun 30, 2025 06:02AM

May 14, 2025 04:13PM

May 14, 2025 10:22AM

Mar 31, 2025 06:19AM

Mar 24, 2025 05:24AM

Mar 20, 2025 10:06AM

Mar 7, 2025 07:07AM Scotiabank Starts ARS Pharmaceuticals Inc (SPRY) at Sector Outperform

Mar 5, 2025 04:11PM

Jan 6, 2025 08:10AM

Dec 12, 2024 02:33PM

Nov 11, 2024 07:03AM

Sep 23, 2024 08:12AM

Sep 9, 2024 04:47PM

Aug 26, 2024 09:31AM ARS Pharmaceuticals (SPRY): EURneffy Approved in EU as First and Only Needle-Free Emergency Treatment of Allergic Reactions

Aug 19, 2024 11:44PM

Aug 9, 2024 12:50PM

Aug 7, 2024 04:55AM

Jun 28, 2024 06:30AM

409,078 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All